Quantcast

Latest pharmaceutical Stories

2014-07-22 08:31:25

SHANGHAI, July 22, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quarter of 2014 after the New York Stock Exchange closes on Wednesday, August 13, 2014 (which will be Thursday morning, August 14, 2014 Shanghai time). The earnings release will be available on the...

2014-07-20 23:00:10

Membrane filtration is a widely used separation technique in the pharmaceutical and biotechnology industries and its adoption rate in Europe and North America is very high - http://www.marketsandmarkets.com/Market-Reports/pharmaceutical-membrane-filtration-market-255408031.html. (PRWEB) July 21, 2014 The “Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nan filtration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein...

2014-07-14 08:26:06

U.S. District Court for the District of Delaware Concurrently Denies Motion For Preliminary Injunction Filed by Antares Pharma, Inc. CHICAGO, July 14, 2014 /PRNewswire/ -- Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced that the U.S. Food and Drug Administration (FDA) has approved Rasuvo(TM), a subcutaneous injectable methotrexate (MTX) therapy delivered in an auto-injector...

2014-07-07 04:20:56

- MAA submission triggers $5 million milestone payment to AcelRx REDWOOD CITY, Calif. and AACHEN, Germany, July 7, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) and Grunenthal Group announced today that Grunenthal has submitted a Marketing Authorization Application (MAA) to the European Medicines Authority for ZALVISO(TM) for the management of moderate to severe acute pain in adult patients in a medically supervised environment. ZALVISO(TM) is a drug-device...

2014-07-01 08:30:06

- Creates an Innovative New Model in Specialty Pharmaceuticals Leadership - DUBLIN, July 1, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has completed the acquisition of Forest Laboratories, Inc. (NYSE: FRX) in a cash and equity transaction currently valued at approximately $28 billion. The combination creates one of the world's fastest-growing specialty pharmaceutical companies, with annual revenues of more than $15 billion anticipated for 2015. In...

2014-06-30 23:23:32

Membrane filtration is a widely used separation technique in the pharmaceutical and biotechnology industries, and its adoption rate in Europe and North America is very high. http://www.marketsandmarkets.com/Market-Reports/pharmaceutical-membrane-filtration-market-255408031.html (PRWEB) June 30, 2014 The “Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nan filtration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein...

2014-06-30 12:26:39

LONDON, June 30, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: JW Pharmaceutical Corporation - Product Pipeline Review - 2014http://www.reportbuyer.com/pharma_healthcare/general_industry/jw_pharmaceutical_corporation_product_pipeline_review_2013.html JW Pharmaceutical Corporation - Product Pipeline Review - 2014 SummaryGlobal Markets Direct's, 'JW Pharmaceutical Corporation - Product Pipeline Review - 2014', provides an overview of the JW...

2014-06-20 08:23:31

SANTA BARBARA, Calif., June 20, 2014 /PRNewswire/ -- SG, LLC announced today that the firm's Alternative Investments Division has increased its investment in GENZUM by up to $20MM, with a portion of the investment reserved for additional growth capital. Dovi Frances, President of SG, LLC, will join GENZUM's board. "With a unique and scalable business model, significant partnerships with leading pharmaceutical companies, and the solid leadership of CEO Chris Achar, COO Rajin Ahuja,...

2014-06-19 23:17:50

Boehringer Ingelheim GmbH, a German pharmaceutical company, recently announced a settlement for approximately 4,000 claims related to injuries and deaths caused by the blood thinner Pradaxa. PHOENIX, AZ (PRWEB) June 19, 2014 The Arizona personal injury firm Phillips Law Group is investigating claims against Boehringer Ingelheim GmbH, the pharmaceutical company who makes the blood thinner Pradaxa. On May 28, a Bloomberg report announced that Boehringer had agreed to settle approximately...

2014-06-19 23:14:27

Fully Integrated CRO Avomeen Invites Pharmaceutical Developers to Connect at BIO 2014 (Booth #1259) San Diego, CA (PRWEB) June 19, 2014 Avomeen Analytical Services will be joining thousands of pharmaceutical companies, researchers, academics, and biotech companies in San Diego for the BIO 2014 International Convention. Their contract services for pharmaceutical development, medical device testing, extractables/leachables, CTM, and more will be highlighted at booth #1259. Knowledgeable...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related